Research has demonstrated that GLP-1RAs significantly inhibit the expression of MMP-2 and MMP-9 in the human ovarian cancer cell line SKOV-3 within a TNF--induced inflammatory microenvironment, while simultaneously upregulating the levels of their inhibitors, tissue inhibitors-1 (TIMP-1) and tissue inhibitors-2 (TIMP-2) [78, 87]
The hexokinase -VDAC1 association favors cancer cell survival through at least two mechanisms: (i) evading apoptosis 79 , and (ii) diminishing the negative feedback inhibition of the enzyme by glucose-6-phosphate 80,81,82,83,84
these medications simulate natural hormones already present in your body
Gastrointestinal Symptoms Nausea, bloating, and gastrointestinal discomfort are common side effects of GLP-1 medications, particularly early in treatment or after dose increases
Posibilidad de retirar el dispositivo si hay intolerancia